Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer among Postmenopausal Women

American Journal of Epidemiology

Volumn 183, Issue 9, 2016, Pages 800-814

  Yang, Hannah P ^a   Murphy, Kelsey R ^a   Pfeiffer, Ruth M ^a   George, Neena ^b   Garcia Closas, Montserrat ^a   Lissowska, Jolanta ^c   Brinton, Louise A ^a   Wentzensen, Nicolas ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DREXEL UNIVERSITY   (United States)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Age at menarche; age at menopause; endometrial cancer; incessant ovulation; lifetime ovulatory cycles; ovarian cancer; ovulation

Indexed keywords

AGE STRUCTURE; ALGORITHM; ANATOMY; CANCER; CONFIDENCE INTERVAL; CORRELATION; HEALTH RISK; LITERATURE REVIEW; MATERNAL HEALTH; RISK FACTOR;

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; EARLY MENOPAUSE; ENDOMETRIUM CANCER; FEMALE; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MENARCHE; MENSTRUAL CYCLE; MIDDLE AGED; ORAL CONTRACEPTIVE USE; OVARY CANCER; OVULATION; POSTMENOPAUSE; AGED; ALGORITHM; CASE CONTROL STUDY; ENDOMETRIAL NEOPLASMS; ODDS RATIO; OVARIAN NEOPLASMS; PHYSIOLOGY; POLAND; RISK FACTOR; STATISTICAL MODEL; YOUNG ADULT;

ADULT; AGED; ALGORITHMS; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LOGISTIC MODELS; MENARCHE; MIDDLE AGED; ODDS RATIO; OVARIAN NEOPLASMS; OVULATION; POLAND; POSTMENOPAUSE; RISK FACTORS; YOUNG ADULT;

EID: 84966656932     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwv308     Document Type: Article

References (34)

1. Hankinson SE, Danforth KN. Ovarian cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. New York, NY: Oxford University Press; 2006:1013-1026.
2. Cook LS,Weiss NS, Doherty JA, et al. Endometrial cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. New York, NY: Oxford University Press; 2006:1027-1043.
3. Fathalla MF. Incessant ovulation-a factor in ovarian neoplasia? [letter]. Lancet. 1971;2(7716):163.
4. Casagrande JT, Louie EW, Pike MC, et al. "Incessant ovulation" and ovarian cancer. Lancet. 1979;2(8135):170-173.
5. Cramer DW, Welch WR. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst. 1983; 71(4):717-721.
6. Fleming JS, Beaugié CR, Haviv I, et al. Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol. 2006;247(1-2):4-21.
7. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst. 1998;90(23):1774-1786.
8. Cramer DW. The epidemiology of endometrial and ovarian cancer. Hematol Oncol Clin North Am. 2012;26(1):1-12.
9. Gates MA, Rosner BA, Hecht JL, et al. Risk factors for epithelial ovarian cancer by histologic subtype. Am J Epidemiol. 2010;171(1):45-53.
10. Moorman PG, Schildkraut JM, Calingaert B, et al. Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States). Cancer Causes Control. 2002;13(9):807-811.
11. Pelucchi C, Galeone C, Talamini R, et al. Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies. Am J Obstet Gynecol. 2007;196(1):83.e1-83.e7.
12. Purdie DM, Bain CJ, Siskind V, et al. Ovulation and risk of epithelial ovarian cancer. Int J Cancer. 2003;104(2): 228-232.
13. Robbins CL, Whiteman MK, Hillis SD, et al. Influence of reproductive factors on mortality after epithelial ovarian cancer diagnosis. Cancer Epidemiol Biomarkers Prev. 2009;18(7): 2035-2041.
14. Schildkraut JM, Bastos E, Berchuck A. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst. 1997;89(13): 932-938.
15. Schildkraut JM, Moorman PG, Bland AE, et al. Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup. Cancer Epidemiol Biomarkers Prev. 2008; 17(3):585-593.
16. Terry KL, Titus-Ernstoff L, McKolanis JR, et al. Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(1):30-35.
17. Tung KH, Goodman MT, Wu AH, et al. Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. Am J Epidemiol. 2003;158(7): 629-638.
18. Tung KH, Wilkens LR, Wu AH, et al. Effect of anovulation factors on pre-and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis. Am J Epidemiol. 2005;161(4):321-329.
19. Webb PM, Green A, Cummings MC, et al. Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst. 1998;90(22):1729-1734.
20. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. Am J Epidemiol. 1992;136(10):1212-1220.
21. McPherson CP, Sellers TA, Potter JD, et al. Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study. Am J Epidemiol. 1996;143(12):1195-1202.
22. Pettersson B, Adami HO, Bergström R, et al. Menstruation span-a time-limited risk factor for endometrial carcinoma. Acta Obstet Gynecol Scand. 1986;65(3):247-255.
23. Odukogbe AA, Adebamowo CA, Adeniji AO, et al. Total ovulating period: any contribution to ovarian carcinogenesis? Afr J Med Med Sci. 2005;34(3):307-309.
24. La Vecchia C, Franceschi S, Gallus G, et al. Incessant ovulation and ovarian cancer: a critical approach. Int J Epidemiol. 1983; 12(2):161-164.
25. Brinton LA, Sakoda LC, Lissowska J, et al. Reproductive risk factors for endometrial cancer among Polish women. Br J Cancer. 2007;96(9):1450-1456.
26. Garcia-Closas M, Brinton LA, Lissowska J, et al. Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study. BMC Cancer. 2007;7:60.
27. Cramer DW, Xu H. Predicting age at menopause. Maturitas. 1996;23(3):319-326.
28. Cramer DW, Xu H, Harlow BL. Does "incessant" ovulation increase risk for early menopause? Am J Obstet Gynecol. 1995; 172(2):568-573.
29. Kotsopoulos J, Lubinski J, Lynch HT, et al. Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2012;21(7):1089-1096.
30. Siskind V, Green A, Bain C, et al. Beyond ovulation: oral contraceptives and epithelial ovarian cancer. Epidemiology. 2000;11(2):106-110.
31. Fathalla MF. Incessant ovulation and ovarian cancer-a hypothesis re-visited. Facts Views Vis Obgyn. 2013;5(4): 292-297.
32. Mumford SL, Steiner AZ, Pollack AZ, et al. The utility of menstrual cycle length as an indicator of cumulative hormonal exposure. J Clin Endocrinol Metab. 2012;97(10): E1871-E1879.
33. Dasharathy SS, Mumford SL, Pollack AZ, et al. Menstrual bleeding patterns among regularly menstruating women. Am J Epidemiol. 2012;175(6):536-545.
34. Mihm M, Gangooly S, Muttukrishna S. The normal menstrual cycle in women. Anim Reprod Sci. 2011;124(3-4):229-236.